EurekAlert! -
21 Dec 2016 07:00
(University of Pennsylvania School of Medicine) NIDDK gave Penn Medicine a $12 Million, four-year grant to establish the Human Pancreas Analysis Program (HPAP). It is focused on procuring and phenotyping pancreatic tissues from individuals with or at risk for Type 1 diabetes, Type 2 diabetes, or other types of pancreatic islet dysfunction characterized by changes in beta cell mass
Share this Article